Activation of THE ADENOSINE A1 RECEPTOR has been linked to the inhibition of cancer cell growth and induction of apoptosis through various molecular pathways, including the suppression of NF-κB activity, a key driver of inflammation and tumorigenesis. This evidence concerns the gene NFKB1 and cancer.